LMO3 Polyclonal Antibody

LIM domain only protein 3 encoded by LMO3 belongs to the rhombotin family of cysteine-rich LIM domain oncogenes. LMO3 is predominantly expressed in the brain. Related family members, LMO1 and LMO2 on chromosome 11, have been reported to be involved in chromosomal translocations in T-cell leukemia. Many alternatively spliced transcript variants have been found for this gene.

The LMO3 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of LMO3 protein expression in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and specificity towards the target protein.

The LMO3 Polyclonal Antibody exhibits exceptional performance in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence. It enables researchers to accurately quantify and visualize LMO3 protein expression in tissues and cells, facilitating comprehensive investigations into its biological functions and molecular mechanisms.

With its superior sensitivity and low background noise, this antibody guarantees reliable and reproducible results, even in challenging experimental conditions. Its robust performance allows for the detection of low-abundance LMO3 protein levels, enabling researchers to explore its role in various physiological and pathological processes.

The LMO3 Polyclonal Antibody is manufactured under stringent quality control standards, ensuring batch-to-batch consistency and reliability. It is supplied as a ready-to-use solution, eliminating the need for time-consuming and error-prone antibody preparation steps.

In summary, the LMO3 Polyclonal Antibody is an indispensable tool for researchers studying LMO3 protein expression and its implications in diverse biological contexts. Its exceptional sensitivity, specificity, and ease of use make it an ideal choice for accurate and reliable detection and analysis of LMO3 protein in various experimental settings.